Sickle cell patients and their families are speaking out, saying their pain is being treated with a one-size-fits-all ...

Sickle cell disease is caused by a single genetic mutation that alters the shape of red blood cells. While the condition causes severe pain and health complications, carriers gain resistance to ...

The Sickle Cell Day Unit at the Royal London Hospital in Whitechapel, London, remains under threat following a temporary six-month trial, prompting sustained opposition from patients, families, and ...

Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.

Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not only realized strong financial performance ...

DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

“The NHF Card programme now serves more than 355,000 active beneficiaries, with total subsidy payments reaching approximately ...

Detailed price information for United Therapeutic (UTHR-Q) from The Globe and Mail including charting and trades.

Jay Bhattacharya, the N.I.H. director, says authorities broke the public’s trust in the Covid era. Now it’s up to outsiders ...

During the opioid crisis in the United States, acute pain management has remained a persistent challenge for both patients and clinicians.